Jing Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jing Xu has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Bin He
Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
1 shared publication - Drena Root
Massachusetts General Hospital
1 shared publication - Javier M. Romero
Harvard University, Cambridge, USA
1 shared publication Jinqiu Zhao
Department of Infectious Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
1 shared publication- Michelle K. Pouria
Massachusetts General Hospital, Boston, USA
1 shared publication - Robert Ackerman
University of Texas at Dallas
1 shared publication
Latest Publications
- 24 September 2019
- Published by SAGE Publications in American Journal of Rhinology & Allergy
- Vol. 34 (1) , 115-121
Efficacy of Glutathione for Patients With Cystic Fibrosis: A Meta-analysis of Randomized-Controlled Studies
The impact of glutathione on pulmonary function remains elusive for patients with cystic fibrosis. The aim of this systematic review and meta-analysis is to explore the influence of glutathione versus placebo on pulmonary function of cystic fibrosis. We search PubMed, EMbase, Web of science, EBSCO, and Cochrane library databases through May 2019, and randomized-controlled trials (RCTs) regarding the effect of glutathione on pulmonary function of cystic fibrosis are included in this meta-analysis. Four RCTs are included. Compared with control group in patients with cystic fibrosis, glutathione treatment shows positive impact on forced expiratory volume 1 second (FEV1) (mean difference [MD] = 0.19; 95% confidence interval (CI), 0.10–0.28; P < .0001) and body mass index (MD = 0.27; 95% CI, 0.02–0.51; P = .03), but has no obvious influence on 6-minute walk test (standard MD = 0.28; 95% CI, −0.08 to 0.64; P = .13), number of exacerbations (MD = −0.10; 95% CI, −0.34 to 0.15; P = .43), abdominal pain or distal intestinal obstruction (risk ratios [RR] = 0.78; 95% CI, 0.32–1.90; P = .58), or hemoptysis (RR = 1.87; 95% CI, 0.43–8.26; P = .41). Glutathione treatment provides some benefits to improve pulmonary function of patients with cystic fibrosis, as evidenced by the increase in FEV1.
- 24 September 2019
- Published by SAGE Publications in American Journal of Rhinology & Allergy
- Vol. 34 (1) , 115-121
Efficacy of Glutathione for Patients With Cystic Fibrosis: A Meta-analysis of Randomized-Controlled Studies
The impact of glutathione on pulmonary function remains elusive for patients with cystic fibrosis. The aim of this systematic review and meta-analysis is to explore the influence of glutathione versus placebo on pulmonary function of cystic fibrosis. We search PubMed, EMbase, Web of science, EBSCO, and Cochrane library databases through May 2019, and randomized-controlled trials (RCTs) regarding the effect of glutathione on pulmonary function of cystic fibrosis are included in this meta-analysis. Four RCTs are included. Compared with control group in patients with cystic fibrosis, glutathione treatment shows positive impact on forced expiratory volume 1 second (FEV1) (mean difference [MD] = 0.19; 95% confidence interval (CI), 0.10–0.28; P < .0001) and body mass index (MD = 0.27; 95% CI, 0.02–0.51; P = .03), but has no obvious influence on 6-minute walk test (standard MD = 0.28; 95% CI, −0.08 to 0.64; P = .13), number of exacerbations (MD = −0.10; 95% CI, −0.34 to 0.15; P = .43), abdominal pain or distal intestinal obstruction (risk ratios [RR] = 0.78; 95% CI, 0.32–1.90; P = .58), or hemoptysis (RR = 1.87; 95% CI, 0.43–8.26; P = .41). Glutathione treatment provides some benefits to improve pulmonary function of patients with cystic fibrosis, as evidenced by the increase in FEV1.
- 26 October 2018
- Published by SAGE Publications in Journal for Vascular Ultrasound
- Vol. 42 (4) , 155-161
Are You Puzzled When Credentialing Entities Ask You for Criteria for External Carotid Artery Stenosis? A Study Correlating Peak Systolic Velocities and Degree of External Carotid Artery Stenosis Based on CT Angiography
External carotid artery (ECA) disease has been understated in the current literature, likely secondary to the lack of clinical neurological symptoms when this vessel is stenotic. However, vascular ultrasound credentialing entities request the adoption of specific criteria for the assessment of the ECA. Our purpose is to determine the ultrasound criteria for the detection of hemodynamically significant stenosis (50%-99%) using computed tomography angiography (CTA) as the reference standard. We included patients who had a carotid ultrasound and a CTA of the neck performed both within a 12-month period. Ultrasound measurements were reviewed for technical accuracy. CTAs were reassessed to determine the degree of stenosis of the bilateral ECAs adopting the North American Symptomatic Carotid Endarterectomy Trial criteria. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were calculated for different peak systolic velocity (PSV) cutoff points to determine the most accurate PSV for detecting 50% to 99% stenosis of the ECA. Receiver operating curve analysis was used to assess diagnostic performance. Of the 536 ECAs included in this study, 13 were noted to be occluded by CTA. Six of these occlusions were accurately detected by ultrasound. There were 82 ECAs with 50% to 99% stenosis on CTA; these vessels had a significantly higher mean PSV compared to ECAs with P < .0001). A cutoff velocity of ⩾200 cm/s demonstrated a sensitivity, specificity, and overall accuracy of 0.84, 0.93, and 0.91, respectively. Using univariate analysis, smoking was significantly associated with the presence of ⩾50% ECA stenosis. We determined that a PSV cutoff of ⩾200 cm/s showed high sensitivity and specificity for detecting 50% to 99% ECA stenosis based on CTA.
- 26 October 2018
- Published by SAGE Publications in Journal for Vascular Ultrasound
- Vol. 42 (4) , 155-161
Are You Puzzled When Credentialing Entities Ask You for Criteria for External Carotid Artery Stenosis? A Study Correlating Peak Systolic Velocities and Degree of External Carotid Artery Stenosis Based on CT Angiography
External carotid artery (ECA) disease has been understated in the current literature, likely secondary to the lack of clinical neurological symptoms when this vessel is stenotic. However, vascular ultrasound credentialing entities request the adoption of specific criteria for the assessment of the ECA. Our purpose is to determine the ultrasound criteria for the detection of hemodynamically significant stenosis (50%-99%) using computed tomography angiography (CTA) as the reference standard. We included patients who had a carotid ultrasound and a CTA of the neck performed both within a 12-month period. Ultrasound measurements were reviewed for technical accuracy. CTAs were reassessed to determine the degree of stenosis of the bilateral ECAs adopting the North American Symptomatic Carotid Endarterectomy Trial criteria. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were calculated for different peak systolic velocity (PSV) cutoff points to determine the most accurate PSV for detecting 50% to 99% stenosis of the ECA. Receiver operating curve analysis was used to assess diagnostic performance. Of the 536 ECAs included in this study, 13 were noted to be occluded by CTA. Six of these occlusions were accurately detected by ultrasound. There were 82 ECAs with 50% to 99% stenosis on CTA; these vessels had a significantly higher mean PSV compared to ECAs with P < .0001). A cutoff velocity of ⩾200 cm/s demonstrated a sensitivity, specificity, and overall accuracy of 0.84, 0.93, and 0.91, respectively. Using univariate analysis, smoking was significantly associated with the presence of ⩾50% ECA stenosis. We determined that a PSV cutoff of ⩾200 cm/s showed high sensitivity and specificity for detecting 50% to 99% ECA stenosis based on CTA.